CBAV Clínica Baviera, S.A.
Clínica Baviera, S.A., a medical company, provides ophthalmologic medicine services in Spain, Germany, and rest of Europe. The company offers refractive, presbyopia, and cataract surgeries; and oculoplastia, corneal disease, dry eye, strabismus, pediatric ophthalmology, glaucoma, neuro-ophthalmological, disorders, and blepharoplasty treatments. It also provides external and internal consultations, surgery treatments, and rehabilitation services. The company was formerly known as Clínica Oftalmológica Baviera, S.L. and changed its name to Clínica Baviera, S.A. in 2000. Clínica Baviera, S.A. was incorporated in 1992 and is based in Madrid, Spain. Clínica Baviera, S.A. is a subsidiary of Aier Eye International (Europe), S.L.U.…
Industry Peers
Diagnostics & ResearchKey Statistics
About Clínica Baviera (BME: CBAV)
›
Clínica Baviera (BME: CBAV) is listed on the Bolsa de Madrid, where its shares trade in EUR. It belongs to the Diagnostics & Research industry, part of the Healthcare sector, and reports about 2,009 employees.
The shares were at 56.20 EUR on 19 November 2026, up 38.4% over 52 weeks. Its 52-week range is 40.20 EUR to 62.00 EUR: the price is 9.4% below the high and 39.8% above the low.
At a market capitalisation of 901.01M EUR, it trades at 19.6 times trailing earnings and 31.8 times forward earnings. The median trailing P/E of its 18 largest Diagnostics & Research peers is 35.8, a discount of 45% for CBAV. It pays a dividend yielding 2.78% (it pays out 55% of its earnings), against a median of 0.73% among the dividend payers in that peer group.
Clínica Baviera reports return on equity of 38.2%, an operating margin of 20.1% and revenue up 13.3% year over year.
Its debt exceeds its cash by 19.82M EUR, a debt-to-equity ratio of 0.64. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health.